Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee.
Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.
Ann Thorac Surg. 2019 May;107(5):1487-1493. doi: 10.1016/j.athoracsur.2018.11.058. Epub 2018 Dec 27.
Surgical resection is the main curative modality for non-small cell lung cancer (NSCLC), but variation in the quality of care contributes to suboptimal survival rates. Improving surgical outcomes by eliminating quality deficits is a key strategy for improving population-level lung cancer survival. We evaluated the long-term survival effect of providing direct feedback on institutional performance in a population-based cohort.
The Mid-South Quality of Surgical Resection cohort includes all NSCLC resections at 11 hospitals in four contiguous Dartmouth Hospital Referral Regions in Arkansas, Mississippi, and Tennessee. We evaluated resections from 2004 to 2013, before and after onset of a benchmarked performance feedback campaign to surgery and pathology teams in 2009.
We evaluated 2,206 patients: 56% preintervention (pre-era) and 44% postintervention (post-era). Preoperative positron emission tomography/computed tomography (46% vs 82%, p < 0.0001), brain scans (6% vs 21%, p < 0.0001), and bronchoscopy (8% vs 27%, p < 0.0001) were more frequently used in the post-era. Patients had 5-year survival of 47% (44% to 50%) in the pre-era compared with 53% (50% to 56%) in the post-era (p = 0.0028). The post-era had an adjusted hazard ratio of 0.85 (95% confidence interval [CI], 0.75 to 0.97; p = 0.0158) compared with the pre-era. This differed by extent of resection (p = 0.0113): compared with the pre-era, the post-era adjusted hazard ratio was 0.49 (95% CI, 0.33 to 0.72) in pneumonectomy, 0.91 (95% CI, 0.79 to 1.05) in lobectomy/bilobectomy, and 0.85 (95% CI, 0.63 to 1.15) in segmentectomy/wedge resections.
Overall survival after surgical resection improved significantly in a high lung cancer mortality region of the United States. Reasons may include better selection of patients for pneumonectomy and more thorough staging.
手术切除是非小细胞肺癌(NSCLC)的主要治疗方法,但治疗质量的差异导致生存率不理想。通过消除质量缺陷来提高手术效果是提高人群肺癌生存率的关键策略。我们评估了在人群队列中提供机构绩效直接反馈对长期生存的影响。
中南部手术切除质量队列包括阿肯色州、密西西比州和田纳西州四个达特茅斯医院转诊区 11 家医院的所有 NSCLC 切除术。我们评估了 2004 年至 2013 年的切除术,在此之前和之后,2009 年对手术和病理团队进行了基准绩效反馈活动。
我们评估了 2206 名患者:56%为干预前(前时代),44%为干预后(后时代)。干预后,正电子发射断层扫描/计算机断层扫描(46%比 82%,p<0.0001)、脑部扫描(6%比 21%,p<0.0001)和支气管镜检查(8%比 27%,p<0.0001)的使用率更高。在前时代,患者的 5 年生存率为 47%(44%至 50%),在后时代为 53%(50%至 56%)(p=0.0028)。与前时代相比,后时代的调整后的危险比为 0.85(95%置信区间[CI],0.75 至 0.97;p=0.0158)。这因切除范围而异(p=0.0113):与前时代相比,在后时代,肺切除术的调整后的危险比为 0.49(95%CI,0.33 至 0.72),肺叶切除术/双叶切除术为 0.91(95%CI,0.79 至 1.05),节段切除术/楔形切除术为 0.85(95%CI,0.63 至 1.15)。
在美国一个肺癌死亡率较高的地区,手术后的总体生存率显著提高。原因可能包括对肺切除术患者的更好选择和更彻底的分期。